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Abstract 
Background: Body mass index (BMI), waist circumference (WC), visceral adiposity index (VAI), triglyceride glucose 
index (TyG), TyG-BMI, and TyG-WC have been reported as markers of insulin resistance or type 2 diabetes mellitus 
(T2DM). However, little is known about the associations between the aforementioned markers and the risk of predia-
betes and diabetes in first-degree relatives (FDRs) of T2DM patients.
Methods: 1544 FDRs of T2DM patients (635 men and 909 women) were enrolled in the initial cross-sectional study 
and all of them finished corresponding examinations. Logistic regression analysis and receiver operating characteristic 
(ROC) curve were used to compare and identify the associations of the six parameters (BMI, WC, VAI, TyG, TyG-BMI and 
TyG-WC) with the prevalence of prediabetes and diabetes. Subsequently, 452 of them were followed-up for an aver-
age of 5 years. Cox proportional hazard regression model was applied to confirm the predictive value of the optimal 
marker.
Results: Among the indices, TyG-WC was more strongly associated with the prevalence of prediabetes and diabetes. 
Compared with participants in the lowest quartile of TyG-WC, the adjusted odds ratio and 95 % CIs for prediabetes 
and diabetes was 11.19 (7.62–16.42) for those in the top quartile of TyG-WC. Moreover, the largest AUC was also 
observed in TyG-WC (0.765, 95 % CIs 0.741–0.789, P < 0.001). The robust predictive value of TyG-WC was further con-
firmed in the follow-up study (HR: 7.13, 95 % CIs 3.41–14.90, P < 0.001).
Conclusions: TyG-WC is a novel and clinically effective marker for early identifying the risks of prediabetes and diabe-
tes in FDRs of T2DM patients.
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Background
The occurrence rate of type 2 diabetes mellitus (T2DM) 
is quite astonishing worldwide, of which is a major risk 
factor for cardiovascular disease and even premature 
mortality [1]. Thus, it is of utmost significance to early 
identify and treat subjects at high risk of developing 
T2DM, though the unclear etiologies and pathological 
process of it. Familial clustering phenomenon of T2DM 
may back the genetic susceptibility to T2DM. Ma et  al. 
[2] demonstrated that first-degree relatives (FDRs) of 
patients with T2DM may have a higher prevalence of 
diabetes than those without a family history of T2DM 
(26.6 versus 9.2  %). Therefore, it is more important to 
early determine the susceptible population vulnerable to 
T2DM via simple and effective diagnostic tools, consid-
ering the enormous population of FDRs.
Previous literature indicated that several effective and 
inexpensive variables, ranging from simple anthropo-
metric measures to more complex models, are closely 
related to insulin resistance (IR) or diabetes. Body mass 
index (BMI) and waist circumference (WC), two clinical 
indices for body fat assessment, are commonly used for 
detecting prediabetes and diabetes risk [3, 4]. Moreover, 
visceral adiposity index (VAI), a mathematical model 
based on BMI, WC, triglyceride (TG) and high-density 
lipoprotein cholesterol (HDL-C), is a more effective tool 
for prediabetes and diabetes prediction [5, 6]. In addition, 
triglyceride glucose index (TyG) as well as TyG-related 
indicators (TyG-BMI and TyG-WC) have been reported 
as excellent surrogate markers of IR, which is deemed to 
be the vital pathological mechanism of T2DM [7, 8]. To 
our knowledge, little is known about the accuracy and 
predictability of these indicators in suffering prediabetes 
and diabetes in FDRs of T2DM patients.
The objectives of the present study were to investigate 
the corresponding associations of the aforementioned 
indicators with the prevalence of prediabetes and diabe-
tes in FDRs of T2DM patients and identify the excellent 
one firstly. Subsequently, a follow-up study was con-
ducted to evaluate the incidence of diabetes in this popu-
lation and further assess the performance of the optimal 
indicator in predicting the risk of T2DM.
Methods
Participants
Stratified random sampling was performed to select 
T2DM patients from the database of Renji hospital 
from January 1995 to 2005. The family of each randomly 
selected subject were contacted by telephone or door-
to-door visit. Only one of the FDRs (including parents, 
children and full siblings) of each T2DM patient was 
randomly selected and invited to our study from Septem-
ber 2005 to August 2009. A total of 2392 FDRs of these 
T2DM patients were invited to the survey. After exclud-
ing ineligible subjects, 2018 FDRs were recruited to the 
study and finished structured questionnaires on their first 
visit. Next, 474 subjects were further excluded accord-
ing to the exclusion criteria including self-reported dia-
betes diagnosis and/or regular diabetic medication use, 
less than 18 or more than 90 years old, pregnant, chronic 
renal or hepatic failure, cancer, taking regular medica-
tion for dyslipidemia and/or hypertension. Finally, 1544 
subjects (635 men and 909 women) were enrolled in the 
cross-sectional study.
To further test whether the optimal marker identified 
through cross-sectional study is useful for predicting 
incident diabetes, we conducted a 5-year prospective 
cohort study including FDRs of T2DM patients diag-
nosed with NGT or prediabetes in the initial study. After 
excluding ineligible participants, 452 of the 1544 FDRs 
completed the annual examinations with the average 
duration of 5 years (Fig. 1).
The study protocol was in compliance with the declara-
tion of Helsinki and approved by the Ethical Committee 
of Renji Hospital, School of Medicine, Shanghai Jiaotong 
University. Written informed consents were signed from 
all participants included in the study.
Measurements
Body height, weight, WC and blood pressure (BP) were 
measured by trained survey personnel. Both height and 
weight measurements were taken in light clothing with-
out shoes. The smallest abdominal circumference was 
measured as WC, which was taken twice and the mean 
value was recorded. Blood pressure was measured three 
times in each subject on the right arm after 5 min resting 
in a sitting position, and the mean value was recorded.
Laboratory analysis
Each participant received a 75 g OGTT after at least 10 h 
of overnight fasting. Blood samples were collected at 0, 
30, 60, 120 and 180  min after the glucose load. Plasma 
glucose levels were measured using the glucose oxidase 
method. Serum insulin levels were obtained using a bio-
antibody technique (Linco, St Louis, MO, USA). Serum 
lipid profiles were tested with an automated biochemi-
cal instrument by radioimmunoassay (RIA) based on 
the double-antibody technique (DPC, Los Angeles, CA, 
USA). HbA1c was measured by the high-performance 
liquid chromatography (HPLC) method with a BIO-RAD 
analyzer (Bio-Rad Variant II; Bio-Rad Laboratories, Her-
cules, CA, USA).
Diagnostic criteria and definition
The 1999 World Health Organization (WHO) diagnostic 
criteria for T2DM was adopted [9].
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Normal glucose tolerance (NGT) was defined as fast-
ing plasma glucose  <6.1  mmol/l and 2-h plasma glu-
cose <7.8 mmol/l. Prediabetes includes isolated impaired 
fasting glucose (IFG), isolated impaired glucose toler-
ance (IGT) and combined glucose intolerance (CGI). 
IFG was defined as fasting plasma glucose between 6.1 
and 7.0  mmol/l and 2-h plasma glucose  <7.8  mmol/l; 
IGT was defined as fasting plasma glucose  <6.1  mmol/l 
and 2-h plasma glucose between 7.8 and 11.1  mmol/l; 
CGI was defined as fasting plasma glucose between 6.1 
Fig. 1 Trial profile. OGTT oral glucose tolerance test, FDR first degree relative, NGT normal glucose tolerance
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and 7.0  mmol/l and 2-h plasma glucose between 7.8 
and 11.1 mmol/l. Diabetes mellitus (DM) was defined as 
fasting plasma glucose  ≥7.0  mmol/l and/or 2-h plasma 
glucose ≥11.1 mmol/l.
BMI was calculated as the body weight (kg) divided by 
the square of body height (m2). VAI and TyG were calcu-
lated using the former formula [10]. VAI: Men: [WC/(39.68  
+  1.88  ×  BMI)]  ×  (TG/1.03)  ×  (1.31/HDL); Women: 
[WC/(36.58 + 1.89 × BMI)] × (TG/0.81) × (1.52/HDL), 
where both TG and HDL levels are expressed in mmol/L. 
The TyG index: Ln [TG (mg/dl) × FPG (mg/dl)/2]. TyG-
BMI: TyG index × BMI. TyG-WC: TyG index × WC (cm).
Incidence was calculated as the number of T2DM cases 
per 100 person years of follow-up starting from the date 
of finishing the initial examination in 2005–2009 to the 
occurrence of diabetes or the final follow-up visit in the 
5th year.
Statistical analysis
All data were analyzed using SPSS version 17.0 for Win-
dows (SPSS, Chicago, IL, USA). Continuous data were 
shown as medians and interquartile ranges (IQR) by 
virtue of the skewed distribution and compared utiliz-
ing Kruskal–Wallis H test or Mann–Whitney U test. 
Adjusted means were calculated and compared with gen-
eral linear models. Categorical variables were expressed 
as percentages and compared with Chi square test. Mul-
tinomial logistic regression was conducted to determine 
the correlations between different factors and the risk of 
prediabetes and diabetes after controlling potential con-
founding factors. For each indicator, odds ratios and 95 % 
CIs of quartiles 2–4 were calculated and compared using 
quartile 1 as the reference. Receiver operating charac-
teristic (ROC) curves were applied to compare the rela-
tive diagnostic strengths of these indicators for correctly 
discriminating prediabetes and diabetes. The area under 
the ROC curve (AUC) was utilized to quantify the over-
all diagnostic accuracy. Indicator with the largest AUC 
was considered as the best marker. The cutoff point of 
the optimal indictor was calculated according to Youden 
Index and the corresponding sensitivity, specificity, posi-
tive and negative predictive values were further assessed 
in the cohort study. Cox proportional hazard regres-
sion was taken to evaluate the predictive power of the 
optimal marker for incident diabetes after adjusting for 




A total of 1544 participants were enrolled in the cross-
sectional study, including 657 with NGT, 423 with pre-
diabetes and 464 with previously undiagnosed diabetes. 
Baseline characteristics of participants, stratified by 
glucose tolerance status, were presented in Table 1. The 
median ages of subjects with NGT, prediabetes and dia-
betes were 47.0, 52.0 and 59.0  years old, respectively 
(P < 0.05). After adjusting for age, subjects with prediabe-
tes and diabetes had higher levels of blood pressure, VAI, 
BMI, WC, TyG, TyG-BMI, TyG-WC, TG, LDL-C and 
lower levels of HDL-C than those with NGT.
Associations of indicators with prediabetes and diabetes 
risk
The ORs and 95  % CIs for prediabetes and/or diabetes 
were progressively increased across quartiles of each 
index after adjusting for age, sex, SBP and DBP (Table 2). 
After direct comparison, TyG-WC presented the highest 
ORs and 95 % CIs for prediabetes and diabetes, reaching 
11.19 (95 % CIs 7.62–16.42) for the top quartile as com-
pared with the bottom quartile (P < 0.001), followed by 
TyG index (Q4 11.04, 95 % CIs 7.57–16.09) and WC (Q4 
5.65, 95 % CIs 3.97–8.04).
The results of ROC analyses and AUCs with their cor-
responding 95 % CIs for VAI, BMI, WC, TyG, TyG-BMI 
and TyG-WC were shown in Fig.  2. For prediabetes, 
the largest AUC was observed in VAI (AUC  =  0.600, 
95  % CIs 0.569–0.631, Grade: D), followed by TyG 
(AUC = 0.557, 95 % CIs 0.526–0.587, Grade: F) and TyG-
WC (AUC  =  0.544, 95  % CIs 0.513–0.575, Grade: F). 
For diabetes, the largest AUC was showed in TyG-WC 
(AUC = 0.767, 95 % CIs 0.743–0.791, Grade: C), followed 
by TyG (AUC = 0.748, 95 % CIs 0.722–0.774, Grade: C) 
and WC (AUC =  0.709, 95  % CIs: 0.682–0.735, Grade: 
C). For mixed prediabetes and diabetes, the largest AUC 
was also showed in TyG-WC (AUC  =  0.765, 95  % CIs 
0.741–0.789, Grade: C), followed by TyG (AUC = 0.759, 
95 % CIs 0.735–0.783, Grade: C) and WC (AUC = 0.703, 
95  % CIs 0.677–0.730, Grade: C). Taking the odds ratio 
and the AUC value into consideration, TyG-WC may be 
regarded as an optimal marker for predicting prediabetes 
and diabetes in those participants.
Clinical outcomes at the final follow‑up
Data from 184 men and 268 women with a median 
age at baseline of 51.0 and 48.0 years respectively were 
observed for an average of 5  years (4.62  ±  0.99). Dur-
ing the 2013 person-years of follow-up, 75 of the 452 
participants were identified as newly occurred diabetes 
patients and the total incidence of diabetes was 3.7 per 
100 person-years. When stratified by quartiles of TyG-
WC, the incidences of diabetes, from Quartile1 to 4, 
were 1.2, 2.1, 5.1 and 9.6 per 100 person-years, respec-
tively. In addition, the cumulative rates of incident 
diabetes from Q1 to Q4 were 5.9, 9.8, 21.9 and 35.9  %, 
respectively (Table 3).
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The predictive value of TyG‑WC
As compared to individuals with the lowest TyG-WC 
(Table  4), those who had the highest TyG-WC were at 
7.13-fold risk of diabetes (95 % CIs 3.41–14.90). The posi-
tive trend between TyG-WC level and diabetes risk was 
attenuated but still remarkable after adjusting for age, 
sex, SBP, DBP, TC and LDL-C (HR: 3.69, 95 % CIs 1.65–
8.28). Additionally, according to the results of ROC curve 
and the Youden Index, the optimal cutoff point of TyG-
WC was 760.06, with the sensitivity of 74.7  % and the 
specificity of 63.1  %. Meanwhile, the positive and nega-
tive predictive values at this point were 28.7 and 92.6 %, 
respectively.
Discussion
In the cross-sectional study, we directly compared six 
parameters (BMI, WC, VAI, TyG, TyG-BMI and TyG-
WC) as predictors of prediabetes and diabetes in FDRs 
of T2DM patients. Overall, we found that TyG-WC out-
performed other predictors with a higher OR and a larger 
AUC. Moreover, in the prospective study, we observed 
that subjects in the highest quartile of TyG-WC had 3.7-
fold risk of diabetes for those in the lowest quartile even 
after the adjustment of potential compounders, which 
indicated that TyG-WC was an independent predictor of 
diabetes in FDRs of T2DM patients.
Previous studies have indicated that both genetic and 
environmental factors contribute to the development 
of diabetes [11–13]. Of note, the prevalence of the mul-
tifactorial disease and potential population of FDRs of 
T2DM patients are increasing obviously with the change 
of lifestyle [14]. FDRs of T2DM patients are regarded as 
high-risk diabetic populations, considering the genetic 
predisposition and the similar lifestyle [15, 16]. In the 
current study, the crude prevalence of diabetes in FDRs 
was 30.1  % and the age-standardized prevalence was 
15.6  %, which was higher than the national prevalence 
of diabetes in China (9.7 %) [17]. Furthermore, Du et al. 
[18] demonstrated that the prevalence of diabetes was 
independently associated with an increasing family his-
tory risk level. Hence, more attention to FDRs of T2DM 
patients should be paid in the clinical diagnosis and 
Table 1 Baseline characteristics of study population
Data were expressed as median (Interquartile range 25–75 %)
Comparisons among NGT, Prediabetes and Diabetes groups were performed after adjusting for age
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WC waist circumference, VAI visceral adiposity index, TyG triglyceride glucose index, 
TyG-BMI combined TyG and BMI, TyG-WC combined TyG and WC, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density 
lipoprotein cholesterol, FPG fasting plasma glucose, 2hPG 2 h postload plasma glucose, FINS fasting serum insulin, 2hINS 2 h postload serum insulin, HbA1c glycated 
hemoglobin A1c
a P < 0.05 versus NGT group
b P < 0.05 versus Prediabetes group
Characteristics NGT Prediabetes Diabetes
Number 657 423 464
Sex (M/F) 256/401 174/249 205/259
Age (years) 47.0 (36.0, 54.0) 52.0 (44.0, 58.0)a 59.0 (50.0, 65.0)a, b
SBP (mmHg) 121.0 (119.0, 122.0) 126.0 (124.0, 127.0)a 129.0 (127.0, 131.0)a, b
DBP (mmHg) 76.0 (75.0, 77.0) 79.0 (78.0, 80.0)a 79.0 (78.0, 80.0)a
BMI (kg/m2) 24.39 (24.03, 24.75) 25.12 (24.68, 25.55)a 25.26 (24.81, 25.70)a
WC (cm) 83.0 (82.1, 83.9) 88.4 (87.3, 89.5)a 92.2 (91.1, 93.3)a, b
VAI 1.70 (1.53, 1.87) 2.39 (2.19, 2.59)a 2.82 (2.62, 3.03)a, b
TyG 8.43 (8.38, 8.48) 8.81 (8.75, 8.87)a 9.21 (9.15, 9.27)a, b
TyG-BMI 206.47 (202.86, 210.08) 222.05 (217.69, 226.42)a 233.45 (228.99, 237.91)a, b
TyG-WC 702.07 (692.13, 712.00) 780.36 (768.35, 792.37)a 851.94 (839.66, 864.22)a, b
TG (mmol/L) 1.33 (1.23, 1.43) 1.71 (1.59, 1.82)a 1.94 (1.82, 2.07)a, b
TC (mmol/L) 4.92 (4.83, 5.00) 5.01 (4.91, 5.11) 5.09 (4.98, 5.19)a
HDL-C (mmol/L) 1.47 (1.44, 1.50) 1.31 (1.27, 1.35)a 1.31 (1.27, 1.34)a
LDL-C (mmol/L) 2.93 (2.87, 2.99) 3.03 (2.96, 3.10)a 3.06 (2.98, 3.13)a
FPG (mmol/L) 5.10 (4.97, 5.22) 5.74 (5.59, 5.89)a 8.65 (8.50, 8.81)a, b
2hPG (mmol/L) 6.06 (5.83, 6.29) 8.65 (8.38, 8.93)a 17.11 (16.83, 17.39)a, b
FINS (μU/ml) 9.23 (8.55, 9.92) 11.19 (10.36, 12.03)a 12.58 (11.73, 13.43)a, b
2hINS (μU/ml) 38.70 (36.09, 41.31) 65.52 (62.36, 68.68)a 43.02 (39.80, 46.25)b
HbA1c (%) 5.50 (5.42, 5.58) 5.75 (5.65, 5.84)a 7.36 (7.27, 7.46)a, b
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treatment of diabetes in an early stage, though the contri-
bution of genetic factors to the pathological development 
of diabetes remains obscure.
The strong relationship between obesity and diabetes 
has been mentioned in many studies [19–21]. Oti et  al. 
[22] found that obesity is closely associated with high 
blood glucose. Matsuda et  al. [23] maintained that adi-
pose tissue is the main source of reactive oxygen species, 
which may contribute to a variety of metabolic problems, 
including obesity-associated IR and T2DM. As simple, 
cheap and noninvasive anthropometric parameters, BMI 
and WC are commonly adopted as useful indicators of 
obesity and metabolic risk. However, recent studies indi-
cated that some populations show unexpected metabolic 
profiles that deviate from the typical dose-response 
relationship between BMI and metabolic disturbances 
[24–26]. In the current study, we also found the associa-
tion between BMI and abnormal glucose metabolism was 
weaker than that of WC when considering the lower odds 
ratios and AUCs of BMI. These results may be explained 
by the different roles of BMI and WC in the evaluation of 
adiposity status [27]. BMI, a measure of body fat based on 
weight and height, stands for general obesity, while WC, a 
measure of abdominal fat, stands for central obesity. The 
National Cholesterol Education Program-Adult Treat-
ment Panel-III suggested that central obesity is an inde-
pendent risk factor for T2DM, and measuring WC is an 
inexpensive tool to screen risk of diabetes [28]. Therefore, 
Table 2 Adjusted odds ratios (OR) for prediabetes and diabetes in quartiles of each index
All indices were divided into quartiles and examined by multinomial logistic analysis. P value was adjusted for age, sex, systolic blood pressure and diastolic blood 
pressure
VAI visceral adiposity index, BMI body mass index, WC waist circumference, TyG triglyceride glucose index, TyG-BMI combined TyG and BMI,  
TyG-WC combined TyG and WC
Parameters Prediabetes OR (95 % CI) P value Diabetes OR (95 % CI) P value Prediabetes + diabetes OR (95 % CI) P value
VAI
Q1 (≤0.981) 1 – 1 – 1 –
Q2 (−1.630) 1.26 (0.86–1.83) 0.239 1.31 (0.89–1.93) 0.172 1.28 (0.94–1.74) 0.123
Q3 (−2.633) 3.16 (2.19–4.57) <0.001 2.28 (1.54–3.38) <0.001 2.72 (1.98–3.75) <0.001
Q4 (≥2.634) 4.07 (2.76–6.00) <0.001 4.57 (3.07–6.81) <0.001 4.23 (3.03–5.90) <0.001
BMI
Q1 (≤22.49) 1 – 1 – 1 –
Q2 (−24.61) 1.40 (0.97–2.01) 0.069 2.05 (1.38–3.03) <0.001 1.64 (1.21–2.24) 0.002
Q3 (−26.82) 1.41 (0.99–2.02) 0.057 2.09 (1.40–3.10) <0.001 1.66 (1.21–2.27) 0.002
Q4 (≥26.83) 1.75 (1.21–2.53) 0.003 2.45 (1.63–3.68) <0.001 2.03 (1.46– 2.80) <0.001
WC
Q1 (≤79.0) 1 – 1 – 1 –
Q2 (−87.0) 1.64 (1.16–2.33) 0.005 4.64 (2.85–7.56) <0.001 2.27 (1.66–3.10) <0.001
Q3 (−94.0) 2.72 (1.88–3.95) <0.001 11.16 (6.83–18.23) <0.001 4.50 (3.22–6.28) <0.001
Q4 (≥94.1) 3.05 (2.05–4.52) <0.001 15.36 (9.27–25.43) <0.001 5.65 (3.97–8.04) <0.001
TyG
Q1 (≤8.269) 1 – 1 – 1 –
Q2 (−8.724) 2.07 (1.45–2.97) <0.001 2.69 (1.68–4.33) <0.001 2.21 (1.60–3.04) <0.001
Q3 (−9.186) 3.19 (2.19–4.64) <0.001 6.66 (4.18–10.63) <0.001 4.16 (2.98–5.80) <0.001
Q4 (≥9.187) 6.54 (4.29–9.97) <0.001 23.04 (14.03–37.82) <0.001 11.04 (7.57–16.09) <0.001
TyG-BMI
Q1 (≤190.27) 1 – 1 – 1 –
Q2 (−214.53) 1.87 (1.29–2.72) 0.001 2.41 (1.56–3.72) <0.001 2.06 (1.50–2.81) <0.001
Q3 (−243.30) 1.92 (1.35–2.73) <0.001 3.79 (2.47–5.82) <0.001 2.50 (1.81–3.46) <0.001
Q4 (≥243.31) 3.52 (2.37–5.23) <0.001 9.04 (5.76–14.18) <0.001 5.27 (3.72–7.47) <0.001
TyG-WC
Q1 (≤668.00) 1 – 1 – 1 –
Q2 (−758.52) 1.67 (1.17–2.38) 0.004 4.39 (2.56–7.50) <0.001 2.19 (1.59–3.02) <0.001
Q3 (−849.62) 4.12 (2.83–6.01) <0.001 15.33 (8.92–26.33) <0.001 6.25 (4.42–8.84) <0.001
Q4 (≥849.63) 4.99 (3.25–7.66) <0.001 38.69 (22.01–68.02) <0.001 11.19 (7.62–16.42) <0.001
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WC may be more effective than BMI. However, WC can-
not sufficiently discriminate between visceral and sub-
cutaneous fat. Accumulating evidence has demonstrated 
that visceral adipose tissue plays more critical roles in 
the development of insulin resistance and diabetes than 
subcutaneous fat. Molecular mechanisms responsible 
for the differences are still under discussion. It has been 
suggested that visceral fat produces more free fatty acid 
Fig. 2 Receiver operating characteristic (ROC) curve analysis of each index. Area under the ROC curve (AUC) and 95 % CIs of each index was shown 
in tables below. VAI visceral adiposity index, BMI body mass index, WC waist circumference, TyG triglyceride glucose index, TyG-BMI combined 
TyG and BMI, TyG-WC combined TyG and WC. Grade: 0.90–1 = excellent (A), 0.80–0.90 = good (B), 0.70–0.80 = fair (C), 0.60–0.70 = poor (D) and 
0.50–0.60 = fail (F)
Table 3 Incidence of diabetes according to TyG-WC quartiles
DM diabetes mellitus, TyG-WC triglyceride glucose-waist circumference index
TyG‑WC Subjects N New DM N Person‑years DM Incidence/100 person‑years Cumulative incidence of DM (%)
Q1 (≤668.00) 153 9 740 1.2 5.9 
Q2 (−758.52) 102 10 477 2.1 9.8
Q3 (−849.62) 105 23 451 5.1 21.9
Q4 (≥849.63) 92 33 345 9.6 35.9
Table 4 Hazard Ratio (95 % CI) of diabetes risk according to TyG-WC quartiles
Model 1 adjusted for age and sex
Model 2 adjusted for Model 1 added SBP, DBP




TyG‑WC Crude Model 1 Model 2 Model 3
Q1 (≤668.00) 1 (referent) 1 (referent) 1 (referent) 1 (referent)
Q2 (−758.52) 1.70 (0.69–4.19) 1.58 (0.64–3.92) 1.33 (0.53–3.30) 1.21 (0.48–3.05)
Q3 (−849.62) 4.01 (1.86–8.66)*** 3.55 (1.60–7.88)** 2.71 (1.21–6.05)* 2.34 (1.01–5.42)*
Q4 (≥849.63) 7.13 (3.41–14.90)*** 6.41 (2.96–13.90)*** 4.87 (2.23–10.65)*** 3.69 (1.65–8.28)**
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than subcutaneous fat, thus increases the risk of IR and 
diabetes [29]. Moreover, visceral adipose secretes various 
inflammatory cytokines and adipokines, which may also 
promote the occurrence of IR and diabetes [30, 31].
Besides obesity, increased FPG levels have also been 
demonstrated as an independent risk factor for develop-
ing T2DM [32–34]. Moreover, elevated TG levels over 
time also enhance the risk of developing diabetes in vari-
ous populations [35–38]. Additionally, Guerrero-Romero 
et al. suggested that, TyG index, the product of FPG and 
TG, could be a surrogate index of insulin resistance due to 
its high sensitivity similar to euglycemic-hyperinsulinemic 
clamp test [6]. Meanwhile, it is also proposed that TyG 
index is a valuable marker for predicting the risk of future 
diabetes in both men and women [39]. Given that insulin 
resistance is the core pathological mechanism of T2DM 
and always occurs before the diagnosis of T2DM [40, 41], 
surrogate indices of insulin resistance might aid in the 
prediction of incident diabetes. In our study, we found 
TyG-WC, the combination of adiposity status and TyG, 
was a better marker for early predicting the risk of pre-
diabetes and diabetes. The superiority of TyG-WC might 
be achieved as TG, FPG and obesity are well validated for 
their roles in IR and the development of diabetes. These 
results also support that both glucotoxicity and lipotoxic-
ity play crucial roles in the pathogenesis of diabetes.
The visceral adiposity index (VAI), a mathematical 
model based on BMI, WC, TG and HDL-C, is another 
predictor of prediabetes and diabetes demonstrated by 
several research, although the relationship might differ 
by ethnicity [42, 43]. In our study, we found the associa-
tion between VAI and diabetes was weaker than that of 
TyG related parameters. However, it was noteworthy that 
VAI was better correlated with prediabetes than with dia-
betes, which was commensurate with the study of Yang 
et al. [44]. Underlying mechanisms are still unclear. Pos-
sible explanation might be that subjects with prediabetes 
have better glucose regulation than those with diabetes, 
so the effect of glucotoxicity was slight in this stage. Thus, 
VAI, an index stands for the condition of obesity and 
lipid levels, is closely related to prediabetes while TyG 
and related parameters are well associated with diabetes.
In the follow-up study, we further evaluated the clini-
cal outcomes of participants and confirmed the predic-
tive value of TyG-WC. Notably, the incidences of diabetes 
were significantly increased in sequence of quartiles of 
TyG-WC. Furthermore, compared with participants in the 
highest quartile of TyG-WC value, the hazard ratio of inci-
dent diabetes was more than threefold for those in the low-
est quartile after adjusting for age, gender, blood pressure 
and other potential compounders, which demonstrated 
the close association between TyG-WC and diabetes risk.
Several limitations may exist in this study. First, the 
results might have potential bias due to the single-center 
design. Second, some potential bias from socio-economic 
background and general diet intake were not well con-
trolled. Third, the number of participants in the follow-
up study was relative small. Fourth, the results were 
obtained from FDRs of diabetes patients, and further 
investigations were required in other populations.
Conclusions
TyG-WC is a valuable marker for predicting the risk of 
prediabetes and diabetes in FDRs of T2DM patients. 
Because it can be easily calculated from routine labora-
tory data, we suggest the possibility of applying this index 
in risk assessment in real clinical practice or epidemio-
logic survey.
Abbreviations
BMI: body mass index; CGI: combined glucose intolerance; HDL-C: high 
density lipoprotein cholesterol; IFG: impaired fasting glucose; IGT: impaired 
glucose tolerance; LDL-C: low density lipoprotein cholesterol; NGT: normal 
glucose tolerance; OGTT: oral glucose tolerance test; TC: total cholesterol; TG: 
triglyceride; TyG: triglyceride glucose index; VAI: visceral adiposity index; WC: 
waist circumference.
Authors’ contributions
SZ, SS and XR attended the data collection, statistical analysis, data inter-
pretation, manuscript writing and revision. TH, YL and YC contributed to the 
acquisition and interpretation of the data. WL and PH contributed to the revi-
sion of the paper. YH contributed to acquisition of funding, study design, and 
revision of the paper. All authors revised and approved the final manuscript. 
All authors read and approved the final manuscript.
Author details
1 Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai 
Jiaotong University, No.160 Pujian Road, Shanghai 200127, China. 2 Depart-
ment of Orthopedic Surgery, Renji Hospital, School of Medicine, Shanghai 
Jiaotong University, No.160 Pujian Road, Shanghai 200127, China. 3 Depart-
ment of Emergency Medicine, Brigham and Women’s Hospital and Harvard 
Medical School, Boston, MA, USA. 
Acknowledgements
The authors thank the staff of the Endocrinology and Metabolism Labora-
tory and the nursing staff for their dedicated assistance in patient sample 
collection.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets supporting the conclusions of this article are included within the 
article and its Additional file 1.
Ethics approval and consent to participate
The study protocol was in agreement with Helsinki declaration and the study 
was approved by the Ethical Committee of Renji Hospital, School of Medicine, 
Shanghai Jiaotong University. Written informed consents were signed from all 
participants included in the study.
Additional file
Additional file 1. Clinical dataset.
Page 9 of 10Zheng et al. J Transl Med  (2016) 14:260 
Funding
This study was supported by the National Natural Science Foundation of 
China (No. 81270946, 81170758, 30670988) and the Foundation from Renji 
Hospital, School of Medicine, Shanghai Jiaotong University (RJZZ14-003).
Received: 15 June 2016   Accepted: 26 August 2016
References
 1. Keating ST, Plutzky J, El-Osta A. Epigenetic changes in diabetes and 
cardiovascular risk. Circ Res. 2016;118(11):1706–22. doi:10.1161/
CIRCRESAHA.116.306819.
 2. Ma H, Gong Y, Liu YY, Song J, Tian HM, Chen T, et al. Prevalence of 
diabetes and prediabetes mellitus in the first-degree relatives of patients 
with type 2 diabetes in Chengdu. Sichuan Da Xue Xue Bao Yi Xue Ban. 
2011;42(2):264–8.
 3. Hunter GR, Chandler-Laney PC, Brock DW, Lara-Castro C, Fernandez 
JR, Gower BA. Fat distribution, aerobic fitness, blood lipids, and insulin 
sensitivity in African–American and European–American women. Obesity 
(Silver Spring). 2010;18(2):274–81. doi:10.1038/oby.2009.229.
 4. Ryoo JH, Park SK, Ye S, Choi JM, Oh CM, Kim SY, et al. Estimation of 
risk for diabetes according to the metabolically healthy status strati-
fied by degree of obesity in Korean men. Endocrine. 2015;50(3):650–8. 
doi:10.1007/s12020-015-0635-5.
 5. Chen C, Xu Y, Guo ZR, Yang J, Wu M, Hu XS. The application of vis-
ceral adiposity index in identifying type 2 diabetes risks based 
on a prospective cohort in China. Lipids Health Dis. 2014;13:108. 
doi:10.1186/1476-511X-13-108.
 6. Du T, Sun X, Huo R, Yu X. Visceral adiposity index, hypertriglyceridemic 
waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int 
J Obes (Lond). 2014;38(6):840–7. doi:10.1038/ijo.2013.181.
 7. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-
Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, et al. The product 
of triglycerides and glucose, a simple measure of insulin sensitivity. Com-
parison with the euglycemic–hyperinsulinemic clamp. J Clin Endocrinol 
Metab. 2010;95(7):3347–51. doi:10.1210/jc.2010-0288.
 8. Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride 
glucose-body mass index is a simple and clinically useful surrogate 
marker for insulin resistance in nondiabetic individuals. PLoS ONE. 
2016;11(3):e0149731. doi:10.1371/journal.pone.0149731.
 9. Alberti KG, Zimmet PZ. Definition, diagnosis and classifica-
tion of diabetes mellitus and its complications. Part 1: diagno-
sis and classification of diabetes mellitus provisional report of a 
WHO consultation. Diabet Med. 1998;15(7):539–53. doi:10.1002/
(SICI)1096-9136(199807)15:7<539:AID-DIA668>3.0.CO;2-S.
 10. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, 
et al. Visceral adiposity index: a reliable indicator of visceral fat function 
associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2. 
doi:10.2337/dc09-1825.
 11. Melnik BC, John SM, Schmitz G. Milk consumption during pregnancy 
increases birth weight, a risk factor for the development of diseases of 
civilization. J Transl Med. 2015;13:13. doi:10.1186/s12967-014-0377-9.
 12. Yang X, Tian H, Zhang F, Zhang C, Li Y, Leng J, et al. A randomised trans-
lational trial of lifestyle intervention using a 3-tier shared care approach 
on pregnancy outcomes in Chinese women with gestational diabetes 
mellitus but without diabetes. J Transl Med. 2014;12:290. doi:10.1186/
s12967-014-0290-2.
 13. Soldati L, Bertoli S, Terranegra A, Brasacchio C, Mingione A, Dogliotti 
E, et al. Relevance of Mediterranean diet and glucose metabo-
lism for nephrolithiasis in obese subjects. J Transl Med. 2014;12:34. 
doi:10.1186/1479-5876-12-34.
 14. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of 
diabetes in Chinese adults. JAMA. 2013;310(9):948–59. doi:10.1001/
jama.2013.168118.
 15. de Visser KL, Landman GW, Kleefstra N, Meyboom-de Jong B, de Visser 
W, te Meerman GJ, et al. Familial aggregation between the 14th and 21st 
century and type 2 diabetes risk in an isolated Dutch population. PLoS 
ONE. 2015;10(7):e0132549. doi:10.1371/journal.pone.0132549.
 16. Zhang J, Yang Z, Xiao J, Xing X, Lu J, Weng J, et al. Association between 
family history risk categories and prevalence of diabetes in Chinese 
population. PLoS ONE. 2015;10(2):e0117044. doi:10.1371/journal.
pone.0117044.
 17. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes 
among men and women in China. N Engl J Med. 2010;362(12):1090–101. 
doi:10.1056/NEJMoa0908292.
 18. Du X, Zhang Y, Gao F, Lu H, Shen Y, Chen R, et al. The influence of family his-
tory risk levels of diabetes on disease prevalence in a high-risk diabetic Chi-
nese population. Diabetes Technol Ther. 2016. doi:10.1089/dia.2016.0023.
 19. Ishola AF, Gerstein HC, Engert JC, Mohan V, Diaz R, Anand SS, et al. Longi-
tudinal relationships between glycemic status and body mass index in a 
multiethnic study: evidence from observational and genetic epidemiol-
ogy. Sci Rep. 2016;6:30744. doi:10.1038/srep30744.
 20. Verma S, Hussain ME. Obesity and diabetes: an update. Diabetes Metab 
Syndr. 2016. doi:10.1016/j.dsx.2016.06.017.
 21. Raghavan S, Pachucki MC, Chang Y, Porneala B, Fox CS, Dupuis J, et al. 
Incident type 2 diabetes risk is influenced by obesity and diabetes 
in social contacts: a social network analysis. J Gen Intern Med. 2016. 
doi:10.1007/s11606-016-3723-1.
 22. Oti SO, van de Vijver SJ, Agyemang C, Kyobutungi C. The magnitude 
of diabetes and its association with obesity in the slums of Nairobi, 
Kenya: results from a cross-sectional survey. Trop Med Int Health. 
2013;18(12):1520–30. doi:10.1111/tmi.12200.
 23. Matsuda M, Shimomura I. Increased oxidative stress in obesity: implica-
tions for metabolic syndrome, diabetes, hypertension, dyslipidemia, 
atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7(5):e330–41.
 24. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Meta-
bolic and body composition factors in subgroups of obesity: what do 
we know? J Clin Endocrinol Metab. 2004;89(6):2569–75. doi:10.1210/
jc.2004-0165.
 25. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body 
mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovas-
cular disease. J Clin Endocrinol Metab. 2006;91(8):2906–12. doi:10.1210/
jc.2006-0594.
 26. Malara M, Keska A, Tkaczyk J, Lutoslawska G. Body shape index versus 
body mass index as correlates of health risk in young healthy sedentary 
men. J Transl Med. 2015;13:75. doi:10.1186/s12967-015-0426-z.
 27. Mansego ML, De Marco G, Ivorra C, Lopez-Izquierdo R, Morcillo S, Rojo-
Martinez G, et al. The nutrigenetic influence of the interaction between 
dietary vitamin E and TXN and COMT gene polymorphisms on waist cir-
cumference: a case control study. J Transl Med. 2015;13:286. doi:10.1186/
s12967-015-0652-4.
 28. Gotto AM. NCEP ATP III guidelines incorporate global risk assessment. Am 
J Manag Care. 2003;1:3.
 29. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: 
defining their role in the development of insulin resistance and beta-cell 
dysfunction. Eur J Clin Invest. 2002;32(Suppl 3):14–23.
 30. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine 
secretion is associated with systemic inflammation in obese humans. 
Diabetes. 2007;56(4):1010–3. doi:10.2337/db06-1656.
 31. Savastano S, Tarantino G, D’Esposito V, Passaretti F, Cabaro S, Liotti A, et al. 
Bisphenol-A plasma levels are related to inflammatory markers, visceral 
obesity and insulin-resistance: a cross-sectional study on adult male 
population. J Transl Med. 2015;13:169. doi:10.1186/s12967-015-0532-y.
 32. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, et al. Normal 
fasting plasma glucose levels and type 2 diabetes in young men. N Engl J 
Med. 2005;353(14):1454–62. doi:10.1056/NEJMoa050080.
 33. Brambilla P, La Valle E, Falbo R, Limonta G, Signorini S, Cappellini F, et al. 
Normal fasting plasma glucose and risk of type 2 diabetes. Diabetes Care. 
2011;34(6):1372–4. doi:10.2337/dc10-2263.
 34. Nichols GA, Hillier TA, Brown JB. Normal fasting plasma glucose and risk of 
type 2 diabetes diagnosis. Am J Med. 2008;121(6):519–24. doi:10.1016/j.
amjmed.2008.02.026.
 35. Hjellvik V, Sakshaug S, Strom H. Body mass index, triglycerides, glucose, 
and blood pressure as predictors of type 2 diabetes in a middle-aged 
Norwegian cohort of men and women. Clin Epidemiol. 2012;4:213–24. 
doi:10.2147/CLEP.S31830.
 36. Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, Israeli E, et al. Changes 
in triglyceride levels over time and risk of type 2 diabetes in young men. 
Diabetes Care. 2008;31(10):2032–7. doi:10.2337/dc08-0825.
Page 10 of 10Zheng et al. J Transl Med  (2016) 14:260 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 37. Maturu A, DeWitt P, Kern PA, Rasouli N. The triglyceride to high-density 
lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of beta-cell 
function in African American women. Metabolism. 2015;64(5):561–5. 
doi:10.1016/j.metabol.2015.01.004.
 38. Zheng S, Zhou H, Han T, Li Y, Zhang Y, Liu W, et al. Clinical characteristics 
and beta cell function in Chinese patients with newly diagnosed type 2 
diabetes mellitus with different levels of serum triglyceride. BMC Endocr 
Disord. 2015;15:21. doi:10.1186/s12902-015-0018-1.
 39. Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, et al. Predicting 
the development of diabetes using the product of triglycerides and 
glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS ONE. 
2014;9(2):e90430. doi:10.1371/journal.pone.0090430.
 40. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: 
a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 
2009;58(4):773–95. doi:10.2337/db09-9028.
 41. Rhee SY, Woo JT. The prediabetic period: review of clinical aspects. Diabe-
tes Metab J. 2011;35(2):107–16. doi:10.4093/dmj.2011.35.2.107.
 42. Liu PJ, Ma F, Lou HP, Chen Y. Visceral adiposity index is associated with 
pre-diabetes and type 2 diabetes mellitus in Chinese adults aged 20–50. 
Ann Nutr Metab. 2016;68(4):235–43. doi:10.1159/000446121.
 43. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performance of the vis-
ceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. 
Lipids Health Dis. 2011;10:88. doi:10.1186/1476-511X-10-88.
 44. Yang Y, Feng Y, Ma X, Chen K, Wu N, Wang D, et al. Visceral adiposity index 
and insulin secretion and action in first-degree relatives of subjects with 
type 2 diabetes. Diabetes Metab Res Rev. 2015;31(3):315–21. doi:10.1002/
dmrr.2615.
